Skip to main content
Log in

Corrective effect of flavonoid-containing preparation extralife on the development of Parkinson’s syndrome

  • Pharmacology and Toxicology
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

Oral administration of flavonoid-containing preparation Extralife (daily dose 40 mg/kg) to animals with modeled Parkinson’s syndrome considerably improved their survival and the main diagnostic and nosological parameters characterizing the state of locomotor functions. The preparation decreased animal mortality, rigidity, disturbances in dynamic muscular work and coordination of movements, and reduced oligokinesia. Experimental data confirm the involvement of mitochondrial enzyme complex I dysfunction in the pathogenesis of the disease and showed the possibility of by-passing this site of the respiratory chain with Extralife.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. G. N. Kryzhanovskii, V. G. Kucheryanu, E. V. Nikushkin, and N. A. Krupina, Ibid., 120, No. 9, 260–262 (1995).

    CAS  Google Scholar 

  2. L. D. Lukyanova, E. L. Germanova, and A. I. Lysko, Vestn. Ross. Akad. Med. Nauk., No. 2, 5–10 (2007).

  3. Manual on Experimental (Preclinical) Testing of New Pharmacological Agents [in Russian], Moscow (2000).

  4. W. Hellenbrand, B. Boeing, B. Robra, et al. Neurology, 47, 644–650 (1996).

    PubMed  CAS  Google Scholar 

  5. G. U. Hoglinger, G. Carrard, P. Michel, et al., J. Neurochem., 86, 1297–1307 (2003).

    Article  PubMed  CAS  Google Scholar 

  6. E. Leroy, R. Boyer, G. Auburger, et al., Nature, 395, 451–452 (1998).

    Article  PubMed  CAS  Google Scholar 

  7. A. Lin, B. Chyi, L. Wu, et al., Chin. J. Physiol., 41, 189–184 (1998).

    PubMed  CAS  Google Scholar 

  8. K. S. McNaught and P. Jenner, Neurosci. Lett., 297, 191–194 (2001).

    Article  PubMed  CAS  Google Scholar 

  9. K. Meuer, C. Pitzer, P. Teismann, et al., J. Neurochem., 97, No. 3, 675–686 (2006).

    Article  PubMed  CAS  Google Scholar 

  10. A. H. Schapira, J. Neurochem., 55, 2142–2145 (1990).

    Article  PubMed  CAS  Google Scholar 

  11. I. Sipos, L. Tretter, and V. Adam-Vizi, J. Neurochem., 84, 112–118 (2003).

    Article  PubMed  CAS  Google Scholar 

  12. R. Smigrodzki, J. Parks, and W. D. Parker, J. Neurobiol. Aging, 25, No. 10, 1273–1281 (2004).

    Article  CAS  Google Scholar 

  13. K. M. Smith, S. Matson, W. R. Matson, et al., Biochim. Biophys. Acta., 1762, No. 6, 616–626 (2006).

    PubMed  CAS  Google Scholar 

  14. K. von Bohlen and O. Halbach, Neurodegener. Dis., 2, No. 6, 313–320 (2005).

    Article  CAS  Google Scholar 

  15. O. Weinreb, S. Mandel, T. Amit, and M. B. H. Youdim, J. Nutrit. Biochem., 15, No. 9, 506–516 (2004).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

__________

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 144, No. 7, pp. 45–49, July, 2007

Rights and permissions

Reprints and permissions

About this article

Cite this article

Luk’yanova, L.D., Storozheva, Z.I. & Proshin, A.T. Corrective effect of flavonoid-containing preparation extralife on the development of Parkinson’s syndrome. Bull Exp Biol Med 144, 42–45 (2007). https://doi.org/10.1007/s10517-007-0249-x

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-007-0249-x

Key Words

Navigation